Risk-reducing salpingo-oophorectomy (RRSO) is standard treatment among women with hereditary breast and ovarian cancer (HBOC). From August 2015 to March 2023, 67 women with HBOC were referred to the gynecologic department of our hospital to consider RRSO. Among them, 29 women selected to be observed and 38 selected to undergo RRSO. Age and rate of previous breast cancer histories were statistically low in observation group. Of those who underwent RRSO, 9 cases were laparotomy and 29 cases were laparoscopic surgery; no severe complication was shown in either group. For promotion of RRSO, we should continue to provide adequate explanation and safe, minimally invasive surgery.
